alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
EXHIBIT 32.2

CERTIFICATION OF THE CHIEF FINANCIAL OFFICER

PURSUANT TO RULE 13A-14(b) OF THE EXCHANGE ACT AND 18
U.S.C. SECTION 1350.

In connection with the Annual Report on Form 10-K of Curis, Inc. (the Company) for the fiscal year
ended December 31, 2006 as filed with the Securities and Exchange Commission on the date hereof (the Report), the undersigned, Michael P. Gray, Vice President of Finance and Chief Financial Officer of the Company, hereby certifies,
pursuant to 18 U.S.C. Section 1350, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial
condition and results of operations of the Company.

Dated: March 2, 2007



/s/ MICHAEL P. GRAYMichael P. GrayChief Operating Officer and Chief Financial Officer(Principal Financial and Accounting Officer)
<TABLE> <S> <C>

<ARTICLE>                     5
<LEGEND>
This schedule contains summary financial information extracted from Form 10-QSB,
3/31/97 and is qualified in it's entirety by reference to such financial 
statements.
</LEGEND>
<MULTIPLIER>                                   1
<CURRENCY>                                     U.S. DOLLARS
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                                DEC-31-1997
<PERIOD-START>                                   JAN-01-1997
<PERIOD-END>                                     MAR-31-1997
<EXCHANGE-RATE>                                           1
<CASH>                                            1,815,883
<SECURITIES>                                              0
<RECEIVABLES>                                       686,705
<ALLOWANCES>                                         32,665
<INVENTORY>                                         157,369
<CURRENT-ASSETS>                                  2,800,009
<PP&E>                                            5,848,312
<DEPRECIATION>                                    1,309,179
<TOTAL-ASSETS>                                    9,391,802
<CURRENT-LIABILITIES>                             2,197,928
<BONDS>                                           5,129,662
<PREFERRED-MANDATORY>                                     0
<PREFERRED>                                               0
<COMMON>                                              9,241
<OTHER-SE>                                        1,824,985
<TOTAL-LIABILITY-AND-EQUITY>                      9,391,802
<SALES>                                           1,360,399
<TOTAL-REVENUES>                                  1,360,399
<CGS>                                               832,552
<TOTAL-COSTS>                                     1,551,525
<OTHER-EXPENSES>                                   (162,204)
<LOSS-PROVISION>                                     11,341
<INTEREST-EXPENSE>                                   87,856
<INCOME-PRETAX>                                    (861,474)
<INCOME-TAX>                                              0
<INCOME-CONTINUING>                                (861,474)
<DISCONTINUED>                                            0
<EXTRAORDINARY>                                           0
<CHANGES>                                                 0
<NET-INCOME>                                       (861,474)
<EPS-PRIMARY>                                          (.13)
<EPS-DILUTED>                                          (.13)
        


</TABLE>
<PAGE>

                                                                    EXHIBIT 32.1

                           CERTIFICATION PURSUANT TO
                            18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                 SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Matritech, Inc. (the "Company") on
Form 10-Q for the period ending June 30, 2004 as filed with the SEC on the date
hereof (the "Report"), I, Stephen D. Chubb, Chief Executive Officer of the
Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, that:

      (1) The Report fully complies with the requirements of section 13(a) or
15(d) of the Securities Exchange Act of 1934; and

      (2) The information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations of the
Company.

A signed original of this written statement required by Section 906 has been
provided to Matritech, Inc. and will be retained by Matritech, Inc. and
furnished to the SEC or its staff upon request.

/s/ Stephen D. Chubb
Stephen D. Chubb
Chief Executive Officer
August 10, 2004
EX-10.61



 Exhibit 10.61 
 SUNESIS PHARMACEUTICALS, INC. 
 AMENDMENT TO

 EXECUTIVE SEVERANCE BENEFITS AGREEMENT 

THIS AMENDMENT TO EXECUTIVE SEVERANCE
BENEFITS AGREEMENT (“Amendment”) is made as of October 24, 2012, by and between SUNESIS PHARMACEUTICALS, INC., a Delaware corporation (the
“Company”), and ADAM R. CRAIG (“Executive”). Capitalized terms not otherwise defined herein shall have the meanings ascribed to them in the Severance Agreement (as defined below). 

RECITALS 
 WHEREAS, the Company and Executive entered into that certain Executive Severance Benefits Agreement dated as of January 31, 2012 (the “Severance Agreement”);

 WHEREAS, Section 6.7 of the Severance Agreement permits the parties to amend the
Severance Agreement upon mutual written consent of the Company and Executive, which shall be signed by an executive officer of the Company after such amendment has been approved by the Board; 

WHEREAS, the Company and Executive wish to amend the Severance Agreement in the manner provided herein; and

 WHEREAS, the Board approves the amendment to the Severance Agreement in the manner provided herein.

 AMENDMENT 
 NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, and intending to be legally bound, the Company and
Executive hereby agree as follows: 
 1. Section 2.1 of the Severance Agreement is hereby amended to add the
following subsection: 
 “(c) Acceleration. The vesting and/or exercisability of the unvested shares subject to
Executive’s then-outstanding Stock Awards shall be automatically accelerated by twelve (12) months on Executive’s Separation from Service.” 
 2. All other terms of the Severance Agreement shall remain in full force and effect. 
 3. Executive acknowledges that he is knowingly and voluntarily entering into this Amendment, and that the Company has not required Executive’s entering into this Amendment as a condition to
Executive’s continued employment by the Company. 
 4. This Amendment does not alter the status of Executive’s
at-will employment relationship with the Company and, subject to the terms of this Amendment, does not in any way 

  
 1 








 
interfere with Executive’s right or the Company’s right to terminate Executive’s employment at any time, with or without Cause or advance notice, which rights are hereby expressly
reserved. 
 5. This Amendment shall be governed by and construed under the laws of the State of California, without
regard to conflict of laws principles. 
 6. This Amendment may be executed in two or more counterparts, each of
which shall be deemed an original, but all of which together shall constitute one and the same instrument. 
 [SIGNATURE PAGE
FOLLOWS] 

  
 2 








 IN WITNESS WHEREOF, the undersigned have
executed this AMENDMENT as of the day and year first set forth above. 
  

			
	COMPANY:
	
	SUNESIS PHARMACEUTICALS, INC.
		
	By:	 	/s/ Daniel N. Swisher, Jr.
		 	Daniel N. Swisher, Jr.
		 	Chief Executive Officer and President


  

			
	EXECUTIVE:
		
		 	/s/ Adam R. Craig
		 	Adam R. Craig
**EXHIBIT 32.2**

 

**CERTIFICATION OF THE CHIEF FINANCIAL OFFICER**

**PURSUANT TO RULE 13A-14(b) OF THE EXCHANGE ACT AND 18 U.S.C. SECTION 1350.**

 

In connection with the Annual Report on Form 10-K of Curis, Inc. (the “Company”) for the fiscal year ended December 31, 2003 as filed with theSecurities and Exchange Commission on the date hereof (the “Report”), the undersigned, Michael P. Gray, Chief Financial Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, that: 

 

(1)     The Report fully complies with the requirementsof Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and 

 

(2)     The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. 

 

Dated:     February 27, 2004
#### Balkar SINGH, Petitioner, v. Eric H. HOLDER, Jr., Attorney General, Respondent.

No. 11-70645.

United States Court of Appeals, Ninth Circuit.

Submitted Dec. 19, 2012.*

Filed Dec. 21, 2012.

Maleeha Haq, Rai & Associates, Har-deep Singh Rai, Hardeep S. Rai, San Francisco, CA, for Petitioner.

OIL, Carlton Frederick Sheffield, U.S. Department of Justice, Civil Division/Office of Immigration Litigation, Washington, DC, Chief Counsel ICE, Office of the Chief Counsel, Department of Homeland Security, San Francisco, CA, for Respondent.

Before: GOODWIN, WALLACE, and FISHER, Circuit Judges.

*

 The panel unanimously concludes this case is suitable for decision without oral argument. *See*Fed. R.App. P. 34(a)(2).

MEMORANDUM **

Balkar Singh, a native and citizen of India, petitions for review of the Board of Immigration Appeals’ (“BIA”) order denying his motion to reopen based on ineffective assistance of counsel. We have jurisdiction under 8 U.S.C. § 1252. We review for abuse of discretion the denial of a motion to reopen, *Avagyan v. Holder,*646 F.3d 672, 674 (9th Cir.2011), and review de novo claims of due process violations, *Colmenar v. INS,*210 F.3d 967, 971 (9th Cir.2000). We deny the petition for review.

The BIA did not abuse its discretion in denying Singh’s motion to reopen as untimely because the motion was filed more than six years after the BIA’s final order of removal, *see*8 C.F.R. § 1003.2(c)(2), and Singh failed to establish the due diligence required for equitable tolling of the filing deadline, *see Avagyan,*646 F.3d at 678-80 (equitable tolling is available to a petitioner who establishes that he suffered from deception, fraud or error, and exercised due diligence in discovering such circumstances).

It follows that Singh’s due process claims fail. *See Colmenar,*210 F.3d at 971 (due process violation occurs “if the proceeding was so fundamentally unfair that the alien was prevented from reasonably presenting his case”); *Najmabadi v. Holder,*597 F.3d 983, 990-91 (9th Cir.2010) (BIA need not “write an exegesis on every *662contention,” just “consider the issues raised, and announce its decision in terms sufficient to enable a reviewing court to perceive that it has heard and thought and not merely reacted” (internal quotations and citation omitted)).

In light of our disposition, we need not reach Singh’s remaining contentions.

PETITION FOR REVIEW DENIED.

**

 This disposition is not appropriate for publication and is not precedent except as provided by 9th Cir. R. 36-3.
<PAGE>

                                                                    EXHIBIT 23.2

               CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS

     We consent to the incorporation by reference in the Registration Statements
of Occam Networks, Inc. pertaining to the Accelerated Networks, Inc. 2000 Stock
Incentive Plan and 2000 Employee Stock Purchase Plan (Form S-8 No. 333-39928),
Accelerated Networks, Inc. 2000 Stock Incentive Plan and 2000 Employee Stock
Purchase Plan (Form S-8 No. 333-55520), Accelerated Networks, Inc. Option Grant
to Mr. Gary J. Sbona (Form S-8 No. 333-72194), Occam Networks, Inc. 1999 Stock
Plan (Form S-8 No. 333-91070) and Occam Networks, Inc. 2000 Stock Incentive Plan
and 2000 Employee Stock Purchase Plan (Form S-8 No. 333-91072) of our report
dated February 6, 2002, with respect to the consolidated financial statements
and schedule of Occam Networks, Inc., for the years ended December 31, 2001 and
2000 included in its Annual Report (Form 10-K) for the year ended December 31,
2002.

                                 /s/ ERNST & YOUNG LLP

Woodland Hills, California
March 26, 2003
<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
     (Replace this text with the legend)
</LEGEND>
<CIK>                         0000885040
<NAME>                        VERMONT PURE HOLDINGS, LTD.
<MULTIPLIER>                                   1
<CURRENCY>                                     U.S. DOLLARS

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                              OCT-31-1999
<PERIOD-START>                                 NOV-01-1998
<PERIOD-END>                                   MAY-01-1999
<EXCHANGE-RATE>                                1
<CASH>                                         626,944
<SECURITIES>                                   0
<RECEIVABLES>                                  4,133,379
<ALLOWANCES>                                   340,239
<INVENTORY>                                    1,783,133
<CURRENT-ASSETS>                               7,053,136
<PP&E>                                         14,040,119
<DEPRECIATION>                                 4,153,799
<TOTAL-ASSETS>                                 28,164,759
<CURRENT-LIABILITIES>                          4,100,141
<BONDS>                                        0
<PREFERRED-MANDATORY>                          0
<PREFERRED>                                    0
<COMMON>                                       10,310
<OTHER-SE>                                     10,508,335
<TOTAL-LIABILITY-AND-EQUITY>                   28,164,759
<SALES>                                        13,680,319
<TOTAL-REVENUES>                               13,680,319
<CGS>                                          4,983,873
<TOTAL-COSTS>                                  4,983,873
<OTHER-EXPENSES>                               7,704,334
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             481,316
<INCOME-PRETAX>                                510,796
<INCOME-TAX>                                   0
<INCOME-CONTINUING>                            510,796
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   510,796
<EPS-BASIC>                                  0.05
<EPS-DILUTED>                                  0.05



</TABLE>
----

**CERTIFICATION        PURSUANT TO RULE 13a-14(b) OR**

**RULE        15d-14(b) and 18 U.S.C. §1350,**

**AS        ADOPTED PURSUANT TO**

**SECTION        906 OF THE SARBANES-OXLEY ACT OF 2002**

|                                                 |                                                                                                                                                                 |                                  |
|------------------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------|
|                                            |                                                                                                                                                            |                             |
| Date: April                11, 2007   | By:                                                                                                                                                        | /s/ Kenneth                Brown |
|                                                 | Kenneth                Brown                                                                                                                                         |
|                                                 | Title:  Chief                Executive Officer and Acting Principal Financial                  Officer of Renewable Energy Resources,                  Inc |
```

[Congressional Bills 108th Congress]
[From the U.S. Government Publishing Office]
[H.R. 802 Introduced in House (IH)]

108th CONGRESS
  1st Session
                                H. R. 802

To amend the Elementary and Secondary Education Act of 1965 to require 
   medically accurate factual information in any course material or 
            instruction on human development and sexuality.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                           February 13, 2003

  Mr. Gutierrez (for himself, Mrs. Capps, Mr. Evans, Mr. Waxman, Mr. 
   Payne, and Mr. Grijalva) introduced the following bill; which was 
        referred to the Committee on Education and the Workforce

_______________________________________________________________________

                                 A BILL

 
To amend the Elementary and Secondary Education Act of 1965 to require 
   medically accurate factual information in any course material or 
            instruction on human development and sexuality.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Medically Accurate Sex Education 
Act''.

SEC. 2. MEDICALLY ACCURATE SEX EDUCATION.

    (a) In General.--The Elementary and Secondary Education Act of 1965 
(20 U.S.C. 6301 et seq.) is amended by inserting after section 9528 (20 
U.S.C. 7908) the following:

``SEC. 9528A. MEDICALLY ACCURATE SEX EDUCATION.

    ``(a) Requirement.--An elementary school or secondary school 
receiving funds under this Act shall not provide factual information 
that is not medically accurate in course material or instruction on 
human development and sexuality, including any sex education, family 
life education, abstinence education, comprehensive health education, 
or character education.
    ``(b) Definitions.--In this section:
            ``(1) The term `factual information' includes information 
        related to medical, psychiatric, psychological, empirical, or 
        statistical statements.
            ``(2) The term `medically accurate' means supported by 
        research, recognized as accurate and objective by leading 
        medical, psychological, psychiatric, and public health 
        organizations and agencies, and, where relevant, published in 
        peer-reviewed journals.''.
    (b) Conforming Amendment.--The table of contents at section 2 of 
the Elementary and Secondary Education Act of 1965 is amended by 
inserting after the item relating to section 9528 the following:

``Sec. 9528A. Medically accurate sex education''.
                                 <all>
```
#### UNITED STATES of America, Plaintiff-Appellee v. Rolando Javier CONTRERAS-GONZALEZ, also known as Homero Medina-Gonzalez, also known as Homero Medina, also known as Rolando Javier Contreras Gonzalez, Defendant-Appellant.

No. 12-20298

Conference Calendar.

United States Court of Appeals, Fifth Circuit.

Dec. 17, 2012.

Renata Ann Gowie, Assistant U.S. Attorney, U.S. Attorney’s Office, Houston, TX, for Plaintiff-Appellee.

Marjorie A. Meyers, Federal Public Defender, Molly Estelle Odom, Esq., Assistant Federal Public Defender, Federal Public Defender’s Office, Houston, TX, for Defendant-Appellant.

Rolando Javier Contreras-Gonzalez, Jonesville, VA, pro se.

Before DAVIS, OWEN, and HIGGINSON, Circuit Judges.

PER CURIAM: *

The Federal Public Defender appointed to represent Rolando Javier Contreras-*335Gonzalez has moved for leave to withdraw and has filed a brief in accordance with *Anders v. California,*386 U.S. 738, 87 S.Ct. 1396, 18 L.Ed.2d 493 (1967), and *United States v. Flores,*632 F.3d 229 (5th Cir.2011). Contreras-Gonzalez has not filed a response. We have reviewed counsel’s brief and the relevant portions of the record reflected therein. We concur with counsel’s assessment that the appeal presents no nonfrivolous issue for appellate review. Accordingly, counsel’s motion for leave to withdraw is GRANTED, counsel is excused from further responsibilities herein, and the APPEAL IS DISMISSED. *See*5th Cir. R. 42.2.

*

 Pursuant to 5th Cir. R. 47.5, the court has determined that this opinion should not be published and is not precedent except under the limited circumstances set forth in 5th Cir. R. 47.5.4.
<PAGE>

                                                                    EXHIBIT 32.2

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Matritech, Inc. (the "Company") on
Form 10-Q for the period ending June 30, 2005 as filed with the SEC on the date
hereof (the "Report"), I, Richard A. Sandberg, Chief Financial Officer of the
Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002, that:

      (1) The Report fully complies with the requirements of section 13(a) or
15(d) of the Securities Exchange Act of 1934; and

      (2) The information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations of the
Company.

A signed original of this written statement required by Section 906 has been
provided to Matritech, Inc. and will be retained by Matritech, Inc. and
furnished to the SEC or its staff upon request.

/s/ Richard A. Sandberg

Richard A. Sandberg
Chief Financial Officer
August 9, 2005
| 1.   | I have reviewed this Form 10-K/A (Amendment No. 1) to the Annual Report of PNM Resources, Inc.; |
|----------------|-------------------------------------------------------------------------------------------------|

| 2.   | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
|----------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 3.   | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report. |
|----------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----